Equity Research Analyst's Stock Ratings: Allergan plc (AGN), Carpenter Technology Corporation (CRS)

Roundview Capital LLC trimmed its holdings in Allergan PLC. (NYSE:AGN) by 35.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC.

The P/E of Allergan plc is now valued at *tba allowing its investors to analyze the company's stock valuation and its shares relative to the income of the company that it makes. Allergan PLC. accounts for about 3.1% of South Street Advisors LLC's investment portfolio, making the stock its 17th largest position. Also, the number of institutional investors holding Allergan Inc in their top 10 positions was flat from 0 to 0 for the same number. Honeywell International Inc. raised its holdings in shares of Allergan 13.6% in the 2nd quarter. WESPAC Advisors SoCal LLC now owns 2,475 shares of the company's stock valued at $601,000 after buying an additional 38 shares in the last quarter. South Street Advisors LLC boosted its holdings in Allergan 54.5% in the second quarter. Finally, WESPAC Advisors SoCal LLC increased its position in Allergan 1.6% during the 2nd quarter. Aviva PLC now owns 287,455 shares of the company's stock worth $69,892,000 after buying an additional 6,722 shares in the last quarter. Currently Allergan plc (AGN) stock is moving with downswing trend. (NYSE AGN) opened at 209.30 on Friday. During the last 52 weeks, the price has been as high as $256.8 and as low as $184.5. The company has a 50 day moving average price of $239.29 and a 200 day moving average price of $222.26. The current market cap of Allergan plc exhibits the basic determinant of asset allocation and risk-return parameters for its stocks. During the key period of last 5 years, Ball Corporation (NYSE:BLL) sales have annually surged 1.00% on average, however its earnings per share growth remained at -9.30%. The company reported $4.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.95 by $0.07. Allergan PLC. The company had revenue of $4.01 billion during the quarter, compared to analysts' expectations of $3.95 billion. Allergan PLC. Allergan PLC.'s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $3.35 EPS. Equities research analysts forecast that Allergan PLC. will post $16.21 EPS for the current fiscal year.

Additionally the company recently announced a dividend for shareholders paid on Friday the 15th of September 2017. Ball Corporation (NYSE:BLL) for the trailing twelve months paying dividend with the payout ratio of 0.00% to its shareholders. The ex-dividend date is Tuesday, May 16th.

Allergan PLC. declared that its Board of Directors has approved a share repurchase plan on Monday, September 25th that permits the company to repurchase $2.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 2.8% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its shares are undervalued. Allergan plc (NYSE:AGN)'s Return on Assets (ROA) of 8.90% is an indicator of how profitable Allergan plc is relative to their total assets. "(AGN)" was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & worldwide trademark & copyright legislation. Allergan plc Ordinary Shares (NYSE:AGN) has declined 3.42% since October 9, 2016 and is downtrending.

A number of equities analysts have recently issued reports on AGN shares. Piper Jaffray Companies set a $205.00 price target on shares of Allergan plc and gave the stock a "hold" rating in a report on Wednesday, February 22nd. Cantor Fitzgerald started coverage on Allergan a report on Friday, June 16th. They gave a "neutral" recommendation and a $231.00 price target for The corporation. Lastly, BidaskClub lifted Allergan. from a "sell" recommendation to a "hold" recommendation in a study on Saturday, Jun 17th. 1 equity analyst has recommended the share with a sell recommendation, eight has issued a hold recommendation and fourteen have issued a buy recommendation to the share. Credit Suisse Group AG reaffirmed a "buy" rating and issued a $274.00 price target on shares of Allergan plc in a report on Tuesday, February 14th.

Allergan, is a multi-specialty healthcare company. The Company is involved in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter (OTC) pharmaceutical products.

Like this


10 October 2017
Nadal thrashes Kyrgios, wins 2nd China Open title
Kyrgios was involved in several exchanges with chair umpire Mohamed Lahyani as he gradually fell out of matters. "An absolute joke", he said.

10 October 2017
Bengaluru firm institutes mental health leave for employees
To support employees, transform practices and embed a whole organisational approach to workplace wellbeing, employers need to make the offer of mental health training a priority.

10 October 2017
Buccaneers sign Patrick Murray as new kicker
After a poor performance against the Giants, Folk had the opportunity to redeem himself against the Patriots in Week 5. Murray has a career field-goal percentage of 80.8, which is a lot higher than what Folk has given the Bucs this year.

10 October 2017
New Jersey Sportsbetting Case to Be Heard By Supreme Court this December
Some states have no language on the matter whatsoever while others have bans on the practice in their state constitutions. The PASPA grandfathered in Nevada , with Montana, Oregon and DE offered the option to provide limited sports betting.

10 October 2017
Argentina, Lionel Messi must end Ecuador woes to seal World Cup spot
There are only a handful of World Cup qualifiers left to go during this worldwide break, with the likes of France, Portugal and Argentina all still sweating on their places in Russian Federation next year.

10 October 2017
Cavs drop 102-94 preseason loss to Wizards
Even though $82 million is a lot to spend on a bench player I believe the lineup switch will benefit the Cleveland Cavaliers . The Cavaliers are 1-5-1 ATS in their last 7 Sunday games and the over is 6-1 in Cavaliers last 7 Sunday games.

10 October 2017
Sixers sign Joel Embiid to five-year, $148 million max extension
If Embiid meets the super-max criteria over the course of the deal, he could earn as high as $178 million, Wojnarowski tweets. A foot injury and subsequent setbacks kept Embiid from playing his first two years in the National Basketball Association .

10 October 2017
YouTube Is Banning Gun Modification Videos After Las Vegas Shooting
Searching for videos on how to modify weapons to have a bump stock are hard to find, and many of them have already been deleted by YouTube.

10 October 2017
Sinclair Broadcast Group, Inc
Pioneer Inv Management stated it has 0.02% in Albemarle Corporation (NYSE:ALB). 1,306,904 shares of the company were exchanged. Sell-side analyst recommendations point to a short term price target of $85.67 on the shares of Applied Optoelectronics, Inc.

10 October 2017
Todd Bowles: Jets RB Bilal Powell day-to-day
Forte, who injured the toe in the Jets' Week 3 victory over the Dolphins , hasn't practiced since that game. Cadet doesn't have a carry or catch for the Jets since they signed him September 27.